ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
    10.
    发明申请
    ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY 审中-公开
    作为预防治疗效果的标记激活

    公开(公告)号:US20100047829A1

    公开(公告)日:2010-02-25

    申请号:US12516682

    申请日:2007-11-28

    IPC分类号: G01N33/53 C07K16/00

    摘要: The present invention provides methods for the determination of the activation level of Receptor Tyrosine kinases, e.g. phosporylated HER3, for the selection of patients for disease treatment. Methods are also provided for the evaluation of the biological and pharmacodynamic effects of an active substance and/or its efficacy in disease treatment, utilizing a tissue sample from a test subject, for example tumor material or normal tissue such as skin or hair follicle. Further, methods for the treatment of HER receptor-associated diseases are disclosed.

    摘要翻译: 本发明提供了用于测定受体酪氨酸激酶活化水平的方法,例如, 磷酸化HER3,用于选择患者进行疾病治疗。 还提供了用于评估活性物质的生物学和药效学效应和/或其在疾病治疗中的功效的方法,利用来自测试对象的组织样品,例如肿瘤材料或正常组织,例如皮肤或毛囊。 此外,公开了治疗HER受体相关疾病的方法。